Viewing Study NCT03982992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2026-02-26 @ 11:16 AM
Study NCT ID: NCT03982992
Status: WITHDRAWN
Last Update Posted: 2024-03-12
First Post: 2019-06-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab
Sponsor: Ludwig-Maximilians - University of Munich
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or … View
None B-Cell Acute Lymphoblastic Leukemia View
None Acute Lymphoblastic Leukemia View
None Acute Lymphoblastic Leukemia in Remission View
None Acute Lymphoblastic Leukemia, Adult View
Keywords:

Keywords

Keyword Brief Keyword Text View
None donor lymphocyte infusion View
None blinatumomab View
None combinatorial View
None minimal residual disease View
None MRD View
None mixed chimerism View
None MC View
None DLI-TARGET View
None acute lymphoblastic leukemia View